Literature DB >> 17444820

Group A streptococcal infections in children.

Andrew C Steer1, Margaret H Danchin, Jonathan R Carapetis.   

Abstract

The group A streptococcus causes the widest range of disease in humans of all bacterial pathogens. Group A streptococcal diseases are more common in children than adults with diseases ranging from pharyngitis and impetigo to invasive infections and the post-streptococcal sequelae--acute rheumatic fever and acute post-streptococcal glomerulonephritis. The global burden of severe group A streptococcal disease is concentrated largely in developing countries and Indigenous populations such as Aboriginal Australians. Control of group A streptococcal disease is poor in these settings and the need for a vaccine has been argued. With an ever-increasing understanding of the group A streptococcus at a molecular level, new and sophisticated vaccines are currently in human trials and the next decade holds exciting prospects for curbing group A streptococcal diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444820     DOI: 10.1111/j.1440-1754.2007.01051.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  30 in total

1.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 2.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

3.  Current practice about the evaluation of antibody to streptolysin O (ASO) levels by physicians working in Antananarivo, Madagascar.

Authors:  Norosoa Julie Zafindraibe; Zely Arivelo Randriamanantany; Davidra Hendriso Rajaonatahina; Ramamonjisoa Andriamahenina; Andry Rasamindrakotroka
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

4.  Varied Presentations of Acute Glomerulonephritis in Children: Single centre experience from a developing country.

Authors:  Kalpana Malla; Moinak S Sarma; Tejesh Malla; Anna Thaplial
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

5.  Rapidly progressing subperiosteal orbital abscess: an unexpected complication of a group-A streptococcal pharyngitis in a healthy young patient.

Authors:  Fulvia Costantinides; Roberto Luzzati; Daniele Tognetto; Gabriele Bazzocchi; Matteo Biasotto; Gian Carlo Tirelli
Journal:  Head Face Med       Date:  2012-10-16       Impact factor: 2.151

6.  Genetic Diversity among Group A Streptococcus Isolated from Throats of Healthy and Symptomatic Children.

Authors:  Smriti Chauhan; Nitin Kashyap; Anil Kanga; Kamlesh Thakur; Anuradha Sood; Lata Chandel
Journal:  J Trop Pediatr       Date:  2016-01-07       Impact factor: 1.165

7.  tRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains.

Authors:  Kyu Hong Cho; Michael G Caparon
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

8.  Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study.

Authors:  Odile Becquet; Jérôme Pasche; Hélène Gatti; Claude Chenel; Michel Abély; Patrice Morville; Christine Pietrement
Journal:  Pediatr Nephrol       Date:  2009-10-30       Impact factor: 3.714

9.  A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia.

Authors:  Ross M Andrews; Therese Kearns; Christine Connors; Colin Parker; Kylie Carville; Bart J Currie; Jonathan R Carapetis
Journal:  PLoS Negl Trop Dis       Date:  2009-11-24

10.  M1T1 group A streptococcal pili promote epithelial colonization but diminish systemic virulence through neutrophil extracellular entrapment.

Authors:  Laura E Crotty Alexander; Heather C Maisey; Anjuli M Timmer; Suzan H M Rooijakkers; Richard L Gallo; Maren von Köckritz-Blickwede; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2009-12-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.